Clinical Trial Update: The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

View source ↗

Summary

The study examining the colonic microbiome and mucosal immunity in inflammatory bowel disease and ankylosing spondylitis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Inflammatory Bowel Disease

Snippet

Sponsor: University of Colorado, Denver | Conditions: Inflammatory Bowel Diseases (IBD), Ankylosing Spondylitis (AS) | Status: ACTIVE_NOT_RECRUITING